The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

Fri, 05th Aug 2022 14:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

----------

Condor Gold PLC - mine developer in Nicaragua - Gets the final results of metallurgical tests for a feasibility study conducted on the La India Open Pit. It was conducted by the Bureau Veritas Laboratories in Richmond, British Columbia. Says low-grade composites averaged 94% at the 75 micron target grind. Says study indicated a net metallurgical recovery of 91%, which will be used in the technical economic models for the forthcoming feasibility study.

----------

Novacyt SA - Surrey-based biotechnology group focused on clinical diagnostics - Launches its first fully freeze-dried direct-to-PCR assays. It enables the transportation of assays at ambient temperatures to remote regions or in areas without a centralised cold storage supply chain.

----------

Schroder British Opportunities Trust PLC - investment company - makes an additional investment into digital-first home healthcare firm Cera Care Ltd. The investment is part of a new funding round to accelerate Cera's growth. Anticipates that the funding round will lead to an uplift in the fair value of its existing holding in Cera of roughly GBP2.1 million, or an approximate uplift on its NAV of 2.8 pence per share, compared to the valuation as at March 31.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Confirms that it has received the first funding tranche of USD1.2 million under its new USD10 million financing facility with Mercer Street Global Opportunity Fund LLC. It is a fund managed by Mercer Street Capital Partners LLC.

----------

Hamak Gold Ltd - British Virgin Islands-based gold exploration firm focused on Liberia - Receives positive channel sampling results at its Nimba license. Intersects significant gold mineralization from its Block-1 grid. Says the results are suggestive of a bulk tonnage gold target.

----------

Star Phoenix Group Ltd - oil and gas company focused on Trinidad and Indonesia - Says its wholly owned subsidiary Range Resources Drilling Services Ltd has submitted three claims of GBP1.8 million against Range Resources Trinidad Ltd in the Supreme Court of Trinidad and Tobago. The claims are in respect of breach of loan, service and equipment rental contracts.

----------

4D Pharma PLC - Leeds, England-based pharmaceutical company - Says its administrators have published a proposal for members and creditors. Says it is uncertain whether rescuing the company in accordance with Paragraph 3,1,a is achievable, considering the uncertainty of the ongoing sale of business process. Aims to is to achieve a better result for the company's creditors as a whole. Notes that a wind-up could be possible.

----------

Critical Metals PLC - Africa-focused natural resources investor - Enters into an investment agreement with its wholly owned subsidiary Critical Metals Mauritius Ltd, Madini Occidental Ltd, and Madini Occidental's shareholders Russell Fryer and Madini Minerals.

----------

Online Blockchain PLC - Ongar, England-based cryptocurrency firm - Adds Optimism to its portfolio of bridges. It is a Layer 2 Ethereum scaling solution has a USD1.20 billion total value locked.

----------

GreenX Metals Ltd - developing Arctic Rift copper project in Greenland - Plans to deploy three advanced all-terrain vehicles for its exploration programme at the Arctic Rift Copper project in Greenland.

----------

First Class Metals PLC - Lancashire, England-based minerals exploration company - Starts ground exploration and reconnaissance work across six of the seven properties.

----------

United Oil & Gas PLC - oil and gas company operating in Egypt, Italy and UK - Finds 7 metres of net oil pay in the Primary Abu Roash C reservoir on its Abu Sennan licence, onshore Egypt. Plans for the testing programme to include both primary and secondary Abu Roash G targets. Optimistic about its prospects, with oil prices remaining high.

----------

Power Metal Resources PLC - London-based metals exploration company focused in North America, Africa and Australia - Starts next exploration phase at its Molopo Farms Complex Project in southwest Botswana. The project is targeting nickel, copper and platinum-group-element mineralisation. The next stage is planned diamond drilling. It is focused on the discovery of economic nickel sulphides and following up on the results from the drill programme completed in 2021.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
6 Jan 2020 08:42

4D Pharma To Trial MRx0518 For Pancreatic Cancer Treatment

4D Pharma To Trial MRx0518 For Pancreatic Cancer Treatment

Read more
6 Nov 2019 11:00

UK WINNERS & LOSERS SUMMARY: Vodafone Up, BT Down On Virgin Media Deal

UK WINNERS & LOSERS SUMMARY: Vodafone Up, BT Down On Virgin Media Deal

Read more
6 Nov 2019 09:36

4D Pharma Says MRx0518 and KEYTRUDA Combination Is Well Tolerated

4D Pharma Says MRx0518 and KEYTRUDA Combination Is Well Tolerated

Read more
5 Nov 2019 15:13

PRESS: Consortium Circles Healthcare Assets Of Fund Manager Woodford

PRESS: Consortium Circles Healthcare Assets Of Fund Manager Woodford

Read more
8 Oct 2019 10:35

WINNERS & LOSERS SUMMARY: Recruitment Firms Drop Amid Weak UK Market

WINNERS & LOSERS SUMMARY: Recruitment Firms Drop Amid Weak UK Market

Read more
8 Oct 2019 09:14

4d Pharma And Merck To Collaborate On Gut Disease Treatments

4d Pharma And Merck To Collaborate On Gut Disease Treatments

Read more
8 Oct 2019 08:30

4D Pharma inks research collaboration agreement with Merck & Co

(Sharecast News) - 4D Pharma has entered into a research collaboration agreement with Merck & Co to discover and develop live biotherapeutics for vaccines.

Read more
30 Sep 2019 09:33

4D Pharma Loss Deepens On Currency Headwinds As Pipeline Progresses

4D Pharma Loss Deepens On Currency Headwinds As Pipeline Progresses

Read more
27 Aug 2019 16:45

4D Pharma Appoints Sangamo Therapeutics Boss Macrae To Board

(Alliance News) - 4D Pharma PLC said Tuesday that it has appointed Sandy Macrae as an independent non-executive director with immediate effect.Macrae currently serves as president & of

Read more
25 Jul 2019 11:26

4d Pharma Picks New Candidate; Encouraging Data On Lead Biotherapeutic

(Alliance News) - 4d Pharma PLC on Thursday announced positive preclinical data on lead biotherapeutic candidate MRx0518 and the identification of a new candidate as well.The new candidate,

Read more
8 Jul 2019 09:29

4d Pharma Begins Live Biotherapeutics Asthma Programme

(Alliance News) - 4d Pharma PLC said Monday it has started a phase I/II study for its lead live biotherapeutic candidate for asthma.The double-blind, placebo-controlled study will enrol 90

Read more
13 Jun 2019 16:07

UK Shareholder Meetings Calendar - Next 7 Days

Friday 14 JuneMP Evans GroupSerabi GoldMonday 17 JuneChallenger 18

Read more
30 May 2019 14:26

DIRECTOR DEALINGS: 4d Pharma Chair Buys GBP15,000 In Shares

LONDON (Alliance News) - 4d Pharma PLC on Thursday said that Chair David Norwood acquired 15,000 shares in the company.On Wednesday, Norwood bought the shares at 100.00 pence each for a of

Read more
21 May 2019 11:27

4D Pharma losses widen as it spends cash on development activities

(Sharecast News) - Biotherapeutics development company 4D Pharma reported net assets of £45.8m in its final results on Tuesday, falling from £69.8m year-on-year.

Read more
21 May 2019 10:29

4d Pharma Annual Loss Widens On Live Biotherapeutic Development Costs

LONDON (Alliance News) - 4d Pharma PLC on Tuesday said its loss widened in 2018 on research and development costs as it continued to develop its live biotherapeutic products, which contain living

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.